Sign in

    John Fieldly

    President, CEO, Chairman of the Board at CCelsius Holdings Inc
    Board
    Since April 2018
    Age
    44 years
    Education
    Holds a Bachelor of Science degree in Accounting from the University of South Florida.
    Tenure
    Joined CELH in January 2012 as Chief Financial Officer, later served as Interim CEO and CFO from March 2017 to March 2018, was appointed as CEO in April 2018, and assumed the role of Chairman of the Board in August 2021.

    Also at Celsius Holdings Inc

    JL
    Jarrod Langhans
    Chief Financial Officer
    KW
    Kyle Watson
    Chief Marketing Officer
    PS
    Paul Storey
    Chief Supply Chain Officer

    About

    John Fieldly is a seasoned executive with deep financial expertise and a background as a Certified Public Accountant in Florida, which has shaped his successful career journey.

    He built his foundation by earning a Bachelor of Science degree in Accounting from the University of South Florida, and he later honed his skills through leadership roles in retail financial management and at companies like Eckerd and Lebhar-Friedman.

    At CELH, his strategic leadership has been instrumental in transforming the company, first as Chief Financial Officer from January 2012, then as Interim CEO and CFO during a transitional phase, and ultimately as CEO since April 2018. His guidance has driven significant growth, operational improvements, and key partnerships that have solidified CELH’s market presence.

    $CELH Performance Under John Fieldly

    Past Roles

    OrganizationRoleDate RangeDetails
    Celsius Holdings, Inc.Interim Chief Executive Officer and Chief Financial OfficerMarch 2017 - March 2018Held dual role prior to becoming President, CEO, and Chairman
    Celsius Holdings, Inc.Chief Financial Officer (CFO)2012 - 2017Served as CFO before his interim dual role
    Celsius Holdings, Inc.Member of the Board of DirectorsMarch 2017 - August 2020*Served as non-chair board member before being appointed Chairman (inferred from context)
    Lebhar-FriedmanLeadership RoleN/AHeld a leadership role prior to joining CELH
    Oragenics, Inc.Leadership RoleN/AHeld a leadership role prior to joining CELH
    Eckerd Drugs, Inc.Leadership RoleN/AHeld a leadership role prior to joining CELH

    Fixed Compensation

    Data from  FY 2024
    Component NameAmountPayment ScheduleAdditional Details
    Base Salary $850,000Payable in installments (at least monthly) Subject to periodic review by the Board; consistent with the Company's practice for its other executives

    Performance Compensation

    Data from  FY 2024

    Annual Cash Bonus

    MetricDetails
    Target Bonus100% of base salary: $850,000
    Breakdown75% tied to financial goals (e.g., revenue, gross profit, adjusted EBITDA) ; 25% tied to organizational & individual performance goals
    Performance LevelsThreshold: 50% payout at 80% target performance ; Target: 100% payout at 100% performance ; Maximum: 150% payout when performance is 116% or above
    Evaluation PeriodCalendar year 2024; payouts finalized post receipt of audited financial statements
    Payout CapMaximum payout capped at 150% of the target bonus (i.e., up to $1,275,000)

    Annual Equity Awards

    MetricDetails
    Grant DateJanuary 1, 2024
    Grant Date Target Value$3,000,000 for the long-term incentive award
    Award PlanIssued under the 2015 Stock Incentive Plan (or its successor)
    Vesting ScheduleNot explicitly detailed for 2024; prior awards (e.g., RSUs) typically vested in equal installments over three years
    Performance MetricsSpecific performance metrics (e.g., financial targets, TSR) for 2024 are not provided; prior metrics have included such financial and strategic organizational goals
    ConditionsSubject to Board approval and the plan’s terms; may include double-trigger change-in-control provisions

    Note: Some details such as exact performance metric thresholds for equity awards and grant date fair value/stock price are not disclosed in the documents.